Stocktoria

Progyny, Inc. PGNY

Nasdaq · stock · Services-Misc Health & Allied Services, NEC · website · IPO 2019-10-25

Progyny, Inc. financials (annual)

Revenue
$105.4M $229.7M $344.9M $500.6M $786.9M $1.09B $1.17B $1.29B 20182019202020212022202320242025
Net income
$661000 -$8.6M $46.5M $65.8M $30.4M $62.0M $54.3M $58.5M 20182019202020212022202320242025
Free cash flow
$1.7M -$4.5M $35.2M $23.9M $77.2M $185.2M $173.7M $191.8M 20182019202020212022202320242025

Bars are annual figures from 2018 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue$1.3B$1.2B$1.1B$786.9M$500.6M$344.9M$229.7M$105.4M
Gross profit$304.5M$253.4M$238.8M$167.3M$112.1M$70.1M$45.5M$19.4M
R&D expense$9.5M
Operating income$85.3M$67.5M$62.2M$23.3M$32.3M$8.3M$9.7M-$3.5M
Income tax$36.9M$28.9M$8.7M-$5.9M-$33.3M-$37.8M$12,000-$1.8M
Net income$58.5M$54.3M$62.0M$30.4M$65.8M$46.5M-$8.6M$661,000
EPS (diluted)$0.65$0.57$0.62$0.30$0.66$0.47$-0.41$0.04
Operating cash flow$210.2M$179.1M$188.8M$80.4M$26.0M$36.2M-$1.5M$2.3M
Free cash flow$191.8M$173.7M$185.2M$77.2M$23.9M$35.2M-$4.5M$1.7M
Cash & equivalents$112.2M$162.3M$97.3M$120.1M$91.4M$70.3M$80.4M$127,000
Total assets$742.4M$607.1M$756.6M$543.0M$358.1M$253.9M$150.4M$41.3M
Total liabilities$226.4M$185.0M$203.2M$166.0M$106.2M$87.0M$36.2M$30.2M
Shareholders' equity$516.0M$422.1M$553.4M$377.0M$251.8M$166.9M$114.3M-$95.1M

Growth · year-over-year · Revenue CAGR 43%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue growth+10.4%+7.2%+38.3%+57.2%+45.2%+50.1%+117.9%
Net income growth+7.7%-12.4%+104.4%-53.8%+41.6%-1396.4%
EPS growth+14.0%-8.1%+106.7%-54.5%+40.4%-1125.0%
Free cash flow growth+10.4%-6.2%+140.0%+222.7%-32.0%-365.2%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.